Cargando…
The volatile and heterogeneous gut microbiota shifts of COVID‐19 patients over the course of a probiotics‐assisted therapy
Autores principales: | Wu, Chunyan, Xu, Qian, Cao, Zhan, Pan, Dengdeng, Zhu, Ying, Wang, Sheng, Liu, Danping, Song, Zhigang, Jiang, Wei, Ruan, Yumeng, Huang, Yongkun, Qin, Nan, Lu, Hongzhou, Qin, Huanlong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713143/ https://www.ncbi.nlm.nih.gov/pubmed/34962356 http://dx.doi.org/10.1002/ctm2.643 |
Ejemplares similares
-
Dysbiosis characteristics of gut microbiota in cerebral infarction patients
por: Li, Hao, et al.
Publicado: (2020) -
Pathogenesis and therapy of radiation enteritis with gut microbiota
por: Yang, Qilin, et al.
Publicado: (2023) -
Metagenomic profiling reveals dominance of gram‐positive bacteria in the gut microbiome shifts associated with immunoglobulin A vasculitis (Henoch–Schönlein Purpura)
por: Cao, Jia, et al.
Publicado: (2021) -
Fecal Microbiota Transplantation Modulates the Gut Flora Favoring Patients With Functional Constipation
por: Zhang, Xueying, et al.
Publicado: (2021) -
Treatment Response, Survival Benefit and Safety Profile of PD-1 Inhibitor Plus Apatinib Versus Apatinib Monotherapy in Advanced Colorectal Cancer Patients
por: Pan, Dengdeng, et al.
Publicado: (2022)